Amrapali Industries Intrinsic Value
Amrapali Industries (AMRAPLIN) median intrinsic value is ₹58.14 from 8 valuation models (range ₹18–₹83), vs current price ₹29.07 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read AMRAPLIN dividend growth for the complete payout history and dividend yield track record.
AMRAPLIN Valuation Methods Summary — DCF, Graham Number & P/E
Amrapali Industries intrinsic value across 8 models vs current price ₹29.07 — upside/downside and value range per method. Analyse AMRAPLIN shareholder distribution to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹83.04 | ₹66.43 - ₹99.65 | +185.7% | EPS: ₹6.92, Sector P/E: 12x |
| Book Value Method | asset | ₹17.69 | ₹15.92 - ₹19.46 | -39.1% | Book Value/Share: ₹17.69, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹58.14 | ₹52.33 - ₹63.95 | +100.0% | Revenue/Share: ₹27724.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹58.14 | ₹52.33 - ₹63.95 | +100.0% | EBITDA: ₹80.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹44.29 | ₹39.86 - ₹48.72 | +52.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹57.02 | ₹51.32 - ₹62.72 | +96.1% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹58.14 | ₹52.33 - ₹63.95 | +100.0% | ROE: 78.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹35.38 | ₹31.84 - ₹38.92 | +21.7% | EPS: ₹6.92, BVPS: ₹17.69 |
AMRAPLIN Intrinsic Value vs Market Price — All Valuation Models
Amrapali Industries fair value range ₹18–₹83 vs current market price ₹29.07 across 8 valuation models. For current market price and key ratios, visit Amrapali Industries screener.
AMRAPLIN Intrinsic Value Analysis — Undervalued or Overvalued?
Amrapali Industries median intrinsic value ₹58.14, current price ₹29.07 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of AMRAPLIN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Amrapali Industries (AMRAPLIN) is ₹58.14 (median value). With the current market price of ₹29.07, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹17.69 to ₹83.04, indicating ₹17.69 - ₹83.04.
Is AMRAPLIN undervalued or overvalued?
Based on our multi-method analysis, Amrapali Industries (AMRAPLIN) appears to be trading below calculated value by approximately 100.0%.
AMRAPLIN Financial Health — Key Ratios vs Industry Benchmarks
Amrapali Industries financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 172.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 78.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 265.99x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
AMRAPLIN Cash Flow Quality — Operating & Free Cash Flow
Amrapali Industries operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |